91 related articles for article (PubMed ID: 23781664)
41. Symptomatic hyperlactataemia in adults on antiretroviral therapy: a single-centre experience.
Fabian J; Venter WD; Mkhabela L; Levin JB; Baker L; Naicker S
S Afr Med J; 2008 Oct; 98(10):795-800. PubMed ID: 19115757
[TBL] [Abstract][Full Text] [Related]
42. The impact of antiretroviral therapy in resource-limited settings and current HIV therapeutics.
Kumarasamy N
Oral Dis; 2016 Apr; 22 Suppl 1():42-5. PubMed ID: 27109271
[TBL] [Abstract][Full Text] [Related]
43. Strongyloidiasis-Related IRIS.
Bar-Yoseph H; Zohar Y; Lorber M
J Int Assoc Provid AIDS Care; 2017; 16(1):8-10. PubMed ID: 27733639
[TBL] [Abstract][Full Text] [Related]
44. Risk Factors of Clinical and Immunological Failure in South Indian Cohort on Generic Antiretroviral Therapy.
Sadashiv MS; Rupali P; Manesh A; Kannangai R; Abraham OC; Pulimood SA; Karthik R; Rajkumar S; Thomas K
J Assoc Physicians India; 2017 Dec; 65(12):34-39. PubMed ID: 29327520
[TBL] [Abstract][Full Text] [Related]
45. [Advances in antiretroviral therapy].
Antunes F
Acta Med Port; 2012; 25(3):193-6. PubMed ID: 23069240
[TBL] [Abstract][Full Text] [Related]
46. Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution.
Williams P; Wu J; Cohn S; Koletar S; McCutchan J; Murphy R; Currier J;
HIV Med; 2009 May; 10(5):290-301. PubMed ID: 19220493
[TBL] [Abstract][Full Text] [Related]
47. Decline in reported AIDS cases in Brazil after implementation of the test and treat initiative.
Pereira GFM; Sabidó M; Caruso A; Benzaken AS
BMC Infect Dis; 2019 Jul; 19(1):579. PubMed ID: 31272415
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countries.
Tassie JM; Malateste K; Pujades-Rodríguez M; Poulet E; Bennett D; Harries A; Mahy M; Schechter M; Souteyrand Y; Dabis F;
PLoS One; 2010 Nov; 5(11):e13899. PubMed ID: 21085709
[TBL] [Abstract][Full Text] [Related]
49. Lack of prior antiretroviral therapy is associated with increased mortality among hospitalized patients with AIDS in São Paulo, Brazil,
Casseb J; Orrico GS; Feijo RD; Guaracy L; Medeiros LA
AIDS Patient Care STDS; 2001 May; 15(5):271-5. PubMed ID: 11530768
[TBL] [Abstract][Full Text] [Related]
50. [Progress on China' s national free antiretroviral therapy strategy in 2002-2014].
Dou Z; Zhang F; Zhao Y; Jin C; Zhao D; Gan X; Ma Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1345-50. PubMed ID: 26850386
[TBL] [Abstract][Full Text] [Related]
51. [Differences in biochemical indexes and AIDS-related complications at baseline in HIV- infected patients with different levels of immune reconstitution after antiretroviral therapy].
Zhong HL; Zhao HP; Li LH; Li QM; Luo D; Zou HC
Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Aug; 44(8):1283-1289. PubMed ID: 37661622
[No Abstract] [Full Text] [Related]
52. A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004-2006.
Lowrance DW; Makombe S; Harries AD; Shiraishi RW; Hochgesang M; Aberle-Grasse J; Libamba E; Schouten E; Ellerbrock T; Kamoto K
J Acquir Immune Defic Syndr; 2008 Nov; 49(3):287-93. PubMed ID: 18845953
[TBL] [Abstract][Full Text] [Related]
53. A Prospective Study on Impact of Early Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-Positive Adults on Immunological Status and Adverse Events.
Kumar V; Singh J
J Glob Infect Dis; 2019; 11(2):73-79. PubMed ID: 31198311
[TBL] [Abstract][Full Text] [Related]
54. 10-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in Haiti.
Pierre S; Jannat-Khah D; Fitzgerald DW; Pape J; McNairy ML
N Engl J Med; 2016 Jan; 374(4):397-8. PubMed ID: 26816026
[No Abstract] [Full Text] [Related]
55. Feasibility and benefits of scaling up antiretroviral treatment provision with the 2010 WHO antiretroviral therapy guidelines in rural Lesotho.
Bygrave H; Saranchuk P; Makakole L; Ford N
Int Health; 2012 Sep; 4(3):170-5. PubMed ID: 24029396
[TBL] [Abstract][Full Text] [Related]
56. Total lymphocyte counts and ART in resource-limited settings.
Moore D; Montaner J
Lancet; 2005 Nov; 366(9500):1831-2. PubMed ID: 16310537
[No Abstract] [Full Text] [Related]
57. AIDS: from crisis management to sustained strategic response.
Piot P
Lancet; 2006 Aug; 368(9534):526-30. PubMed ID: 16890840
[No Abstract] [Full Text] [Related]
58. Subdividing ART patients and analyzing the medical burden by modeling of CD4 cell count.
Min L; Qunwei W
J Family Med Prim Care; 2023 Feb; 12(2):352-359. PubMed ID: 37091020
[TBL] [Abstract][Full Text] [Related]
59. Scaling-up antiretroviral treatment in Southern African countries with human resource shortage: how will health systems adapt?
Van Damme W; Kober K; Kegels G
Soc Sci Med; 2008 May; 66(10):2108-21. PubMed ID: 18329774
[TBL] [Abstract][Full Text] [Related]
60. Duplicate analysis method: a cheaper alternative to commercial IQC materials in limited resource settings for monitoring CD4 testing.
Shete A; Singh DP; Mahajan B; Kokare A; Paranjape R; Thakar M
AIDS Res Ther; 2015; 12():25. PubMed ID: 26279667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
